According to IMARC Group, the global vaccine adjuvants market size reached USD 1,223.6 Million in 2025 and is projected to reach USD 2,987.6 Million by 2034, expanding at a CAGR of 10.11% during 2026–2034. This robust vaccine adjuvants market size growth reflects the rising incidence of infectious diseases, landmark advances in immunology, escalating awareness of rare diseases, and...